Vascular endothelial growth factor is a target gene for estrogen receptor and contributes to breast cancer progression

Advances in Experimental Medicine and Biology

Volumn 617, Issue , 2008, Pages 437-444

  Applanat, Martine Perrot ^a   Buteau Lozano, Helene ^a   Herve, Marie Astrid ^a   Corpet, Armelle ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FULVESTRANT; LUCIFERASE; TAMOXIFEN; VASCULOTROPIN; VASCULOTROPIN 165; ANTIESTROGEN; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BREAST CARCINOMA; CANCER GROWTH; CELL PROLIFERATION; CELL STRAIN MCF 7; CONFERENCE PAPER; CONTROLLED STUDY; ENDOTHELIUM CELL; ESTROGEN ACTIVITY; ESTROGEN RESPONSIVE ELEMENT; EXPERIMENTAL MODEL; EXPRESSION VECTOR; FEMALE; GENE CONSTRUCT; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION REGULATION; TUMOR VASCULARIZATION; ANIMAL; ARTICLE; BREAST TUMOR; CANCER TRANSPLANTATION; CELL CULTURE; DISEASE COURSE; DNA RESPONSIVE ELEMENT; DRUG EFFECT; EXPERIMENTAL NEOPLASM; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; WESTERN BLOTTING;

MURINAE; MUS;

ANIMALS; BLOTTING, WESTERN; BREAST NEOPLASMS; DISEASE PROGRESSION; ESTRADIOL; ESTROGEN ANTAGONISTS; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MICE, SCID; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; PROMOTER REGIONS (GENETICS); RESPONSE ELEMENTS; TAMOXIFEN; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 46749105194     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-69080-3_42     Document Type: Conference Paper

References (18)

1. Folkman J (1995) Angiogenesis in cancer, vascular, rheumatoid, and other disease. Nat Med 1, 27-31.
2. Obermair A, Kucera E, Mayerhofer K, et al. (1997) Vascular endothelial growth factor (VEGF) in human breast cancer: correlation with disease-free survival. Int J Cancer 74:455-8.
3. Yoshiji H, Harris SR, Thorgeirsson UP (1997) Vascular endothelial growth factor is essential for initial but not continued in vivo growth of human breast carcinoma cells. Cancer Res 57:3924-8.
4. Osborne CK, Hobbs K, Clarke GM (1985) Effects of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice. Cancer Res 45:5846590
5. Cullinan-Bove K, Koos RD (1993). Vascular endothelial growth factor/vascular permeability factor expression on the rat uterus: rapid stimulation by estrogen correlates with estrogeninduced increases in uterine capillary permeability and growth. Endocrinology 133:829-7.
6. Shiffren JL, Tseng J, Zaloudek C, et al. (1996) Ovarian steroid regulation of vascular endothelial growth factor in human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis. J Clin Endocrinol Metab 81:3112-18.
7. Bausero P, Cavaillé F, Meduri G, et al. (1998) Paracrine action of vascular endothelial growth factor in the human endometrium: production and target sites, and hormonal regulation. Angiogenesis 2:167-82.
8. Nakamura J, Savinov A, Lu Q, et al. (1996) Estrogen regulated vascular endothelial growth/ permeability factor expression in 7,12-dimethylbenz(a) anthracene-induced rat mammary tumors. Endocrinology 137:5589-96.
9. Dabrosin C, Margetts PJ, Gauldie J (2003) Estradiol increases extracellular levels of vascular endothelial growth factor in vivo in murine mammary cancer. Int J Cancer 107:535-40.
10. Ruohola JK, Valve M, Karkkainen MJ, et al. (1999) Vascular endothelial growth factors are differentially regulated by steroid hormones and antiestrogens in breast cancer cells. Mol Cell Endocrinol 149:29-40.
11. Buteau-Lozano H, Ancelin M, Lardeux B, et al. (2002) Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta. Cancer Res 62:4977-84.
12. Stoner M, Wormke M, Saville B, et al. (2004) Estrogen regulation of vascular endothelial growth factor gene expression in ZR-75 breast cancer cells through interaction of estrogen receptor α?and SP proteins. Oncogene 23:1052-63.
13. Ferrara N, Davis-Smith T (1997) The biology of vascular endothelial growth factor. Endocr Rev 18:4-25.
14. Tisher E, Mitchell R, Hartman T, et al. (1991) Multiple protein forms are encoded through alternative exon splicing. J Biol Chem 266:11947-54.
15. Mueller MD, Vigne JL, Minchenko A, et al. (2000) Regulation of vascular endothelial growth factor (VEGF) gene transcription by estrogen receptor αand β. Proc Natl Acad Sci USA 97:10972-7.
16. Kazi AA, Jones JM, Koos RD (2005) Chromatin immunoprecipitation analysis of gene expression in the rat uterus in vivo: estrogen-induced recruitment of both estrogen receptor alpha and hypoxia-inducible factor 1 to the vascular endothelial growth factor promoter. Mol Endocrinol 19:2006-19.
17. Zhang HT, Scott PA, Morbidelli L, et al. (2000). The 121 amino acid isoform of vascular endothelial growth factor is more strongly tumorigenic than other splice variants in vivo. Br J Cancer 83:63-68.
18. Guo P, Fang Q, Tao HQ, et al. (2003). Overexpression of vascular endothelial growth factor by MCF-7 breast cancer cells promotes estrogen-independent tumor growth in vivo. Cancer Res 63:4684-91.